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OBJECTIVE: For many years, it was believed that medullary regeneration could not occur, although currently there are many
trials using neurotrophic factors, stem cells, fetal medulla grafts, peripheral nerve grafts, and antibodies against myelin-associated
proteins that demonstrate the existence of the possibility of spinal cord regeneration. The purpose of this study was to investigate
the action of neurotrophin-3, a novel neurotrophic factor.
METHODS: The New York University impactor, a standardized device for delivery of spinal cord injuries was used on 33 rats,
which were divided into 2 groups: a control group receiving distilled water intraperitoneally and a treatment group receiving
neurotrophin-3 intraperitoneally.
RESULTS: Using the Basso, Beattie, and Bresnahan scale, the locomotor recovery curve for the neurotrophin-3 treated group
was superior to that of the control group (P < 0.05); the administration of neurotrophin-3 was associated with the absence of
deaths, while the control group showed a 28.5% (P = 0.026) mortality rate. Other parameters (hematuria rate and histological
analysis) showed no significant differences.
CONCLUSIONS: Based on these results, it appears that a strong relationship exists between the use of neurotrophin-3 in rats
with spinal cord injury and better functional recovery.
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INTRODUCTION
For many years, axonal regeneration in the central nerv-
ous system has been an objective targeted by many inves-
tigators in the medical area. Over the last 2 decades, many
approaches have resulted in axonal growth following tis-
sue injuries. Thus, the long-held belief that spinal cord re-
generation is unattainable has been refuted. However, it is
known that penetrating damage to the spinal cord of mam-
mals results in interruption of both ascending and descend-
ing spinal cord pathways. Responses of the body to dam-
age include retraction of the proximal stump of the axon,
neuronal atrophy, and neuronal death.1
Efforts to prevent these sequelae and provide neuronal
regeneration arise from the concept of generating an envi-
ronment suitable for axonal growth in the central nervous
system (CNS). Currently, the most investigated approaches
are the use of neurotrophic factors for CNS injuries, pe-
ripheral or fetal nervous tissue grafts, and antibodies (anti-
myelin-associated neuronal growth-inhibiting proteins).
Examples of successful trials are the studies of Schnell
et al,2 Bregman et al,3 Cheng et al,4 and Grill et al.5 Schnell
et al2 studied the action of neurotrophic factors,
neurotrophin-3 (NT-3), nerve growth factor (NGF), and
brain-derived neurotrophic factor (BDNF), on spinal cord
injuries in rats following transection of the corticospinal
tract. The corticospinal tract plays a major role in nerve
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conduction that determines voluntary motricity in mam-
mals.6 These substances were injected into the injury and
were shown to be highly effective in axonal regeneration,
the most successful one being NT-3.
Neurotrophin-3 is a neurotrophic substance only re-
cently synthesized. This protein belongs to the family of
neurotrophins, the amino acid sequence of which is simi-
lar in humans, rats, and pigs. Neurotrophin-3 is important
for the development and maintenance of the neuronal popu-
lation, promoting its differentiation. Neurotrophin-3 is also
important for the formation of the substantia nigra and the
pyramidal tract that is responsible for motor activity.2
Bregman et al3 showed that following damage to the spi-
nal cord of rats, the neutralization by antibodies of myelin-
derived inhibitors of axonal growth promoted (in the CNS)
growth of the cortical spinal, cerulospinal and raphespinal
tracts and induced functional recovery of locomotion. The
axonal growth distance obtained in this trial was such that
it exceeded the injured area; also, the functional recovery
of locomotion was so expressive that it almost equalled that
of normal uninjured rats in some of the evaluation tests.
Cheng et al5 reported the use of a peripheral nerve
bridge inserted into the region of the transected spinal cord
of rats and fixed with a mixture of fibrin glue and acidic
fibroblast growth factor (aFGF), promoting corticospinal
growth and functional recovery of axons.
Grill et al5 grafted transgenically modified cells onto
the medullary injury site of rats to release NT-3, obtaining
corticospinal axon growth and partial recovery of the ax-
onal function.
Among many neurotrophic factors studied, the one with
the best response concerning corticospinal axonal regen-
eration was NT-3.2,7 The studies showed that NT-3 is supe-
rior to NGF and BDNF. In addition to the neuronal growth
achieved with NT-3, it seems that this substance facilitates
the formation of new synapses that are important in
neurofunctional recovery.7, 8
OBJECTIVE
The purpose of this study was to determine whether in-
traperitoneal administration of NT-3 is a treatment effective
to stimulate neural regeneration of spinal cord injury in rats.
Both NT-3 and the distilled water placebo were administered
intraperitoneally because this route allows quick and com-
plete absorption; moreover it is practical, reproducible, and
virtually free of complications when properly handled.
MATERIALS AND METHODS
Young adult Wistar rats, weighing between 300 and 500
g, were the subjects of our trial. The rats were supplied by
the animal house of the Institute of Orthopedics and Trau-
matology and were accommodated there during the pre-
and postoperative periods. Each cage accommodated 3 rats
with free access to water and food; animals were kept warm
and were monitored throughout the trial. Ethical standards
for use of animals in medical trials were observed, so that
the animals were never mistreated or subjected to pain or
suffering.
To produce spinal cord injuries in our study, we used a
thoroughly tested and recognized apparatus, the New York
University (NYU) impactor (Figure 1), a computerized de-
vice developed by the New York University and intended
to produce an impact using the fall of a weight. 9 The NYU
impactor consists of an interfacing device (instrumentation),
PC-compatible IBM microcomputer, VGA monitor, inter-
face plate with parallel exit and timer, and the NYU
impactor Software. Basically, this instrument controls and
monitors the fall of a rod equipped with a weight targeted
to impact the spinal cord. This fall is monitored by multi-
ple sensors connected to a computer that records the
weight’s height of fall and speed of fall, as well as the in-
stant of impact with the dura mater, the change of posi-
tion of the spinal cord after the impact, and the spinal cord
compression caused by the fall, in addition to identifying
errors in the process. Therefore, this medullary injury
model, if appropriately used, is practical and reproducible,
which is important for injury standardization and investi-
gation.
Lesional / management technique
All rats received sodium pentobarbital anesthesia
intraperitoneally (40 mg/kg body weight). After anesthetic
induction, animals were tricotomized in the dorsal region and
Figure 1 - NYU IMPACTOR
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positioned on the surgical table. Firstly we made a 4-cm long
dorsal median incision in the skin; then we opened the
aponeurotic and muscular planes (major muscle dorsal and
paravertebral muscle). In this way, we exposed the poste-
rior portion (spinal processes and laminae) of vertebrae T8,
T9, T10, T11, T12, and L1. We then identified the T10 po-
sition through tendinous insertion of the major muscle dor-
sal and rib counting. The spinal process of T9 and T10 was
excised using a micropunch, followed by laminectomy at
T10 with exposure of the dura mater. An approximately 3-
mm long access to the dura mater was formed, enough to
accommodate the weight of the NYU impactor. After the
laminectomy, we placed the rat on a small pad and fixed
the T8 and T11 spinal processes using two clamps fastened
to the base of the NYU impactor. We positioned the spine
movement sensors over the T9 transverse process and fas-
tened the contact sensor to a structure of the incision. First
we placed the weight at height zero in order to achieve cor-
rect positioning; then we moved it to the height of fall, stand-
ardized at 12.5 mm for all cases. Then we checked the cali-
bration of all sensors and proceeded with the dropping of
the weight. After the free fall, the weight was left to com-
press the spinal cord for 15 seconds and was then removed.
The PC screen was checked for interferences and to make
sure everything was in good order.
A total of 33 male Wistar rats were divided into 2
groups following experimental medullary injury: one re-
ceiving distilled water (control group) and the other receiv-
ing NT-3, 1 mg per rat (treatment group).
The control group included 14 rats weighing between
304 g and 387 g. In this group, after the spinal cord injury
and after the synthesis of the incised planes, 0.4 mL dis-
tilled water was injected intraperitoneally into each rat. The
treatment group included 19 rats weighing between 295 g
and 376 g. After the medullary injury and after the syn-
thesis of the incised planes, each rat of the treatment group
was injected intraperitoneally with 1 mg of neurotrophin-
3 diluted in 0.4 mL of distilled water.
The different number of animals included in the groups
(14 vs 19, control vs NT-3 group, respectively) occurred
because there was excess study drug and because it was
expected that some of the rats in the study might die. Con-
sequently, the number of subjects in the treated group was
increased.
After the drug or distilled water was introduced
intraperitoneally, we closed the dorsal incision following
the incision planes, using 3.0 nylon thread.
Postoperative period
During the immediate postoperative period, the animals
were placed under a heating source, each one in its box,
until fully recovered from anesthesia. The heat source was
then removed, and food and water were placed inside the
boxes, which were then closed. Each rat received cefazolin
(50 mg/kg/day, intraoperatively and for 10 postoperative
days) to prevent infections central nervous system, soft tis-
sue and urinary infections. All rats presenting hematuria
were treated with levofloxacin at 7 mg/kg/day for 14 days,
due to suspicion of urinary infection.
Still aiming at preventing urinary infection, the rats
were subjected to bladder compression twice a day during
the first 5 days, and then once a day for the next 2 days.
Methods employed to evaluate the results
Results were analyzed under 4 categories: function, his-
tology, mortality, and frequency of hematuria. Functional
and histological results are direct parameters of spinal cord
regeneration, while mortality and frequency of hematuria
are indirect parameters of spinal cord regeneration.
The functional studies were performed on postopera-
tive days 2, 9, 16, 23, and 30 according to the Basso,
Beattie, and Bresnahan (BBB locomotive scoring criteria.10
This evaluation was performed in a 1-m diameter circle for
4 minutes for each rat. The range of motion of each joint
of the posterior limbs (hips, knees, and ankles), position
of the abdomen, body sustentation, position of the poste-
rior paws, balance, locomotion, step coordination, and tail
position were evaluated. The rats could be scored from 0
to 21 according to these criteria, where 0 means absence
of motility and 21 means normal motility, balance, and co-
ordination. To facilitate the practical and statistical com-
parisons, the arithmetic mean of the score of right and left
posterior limbs was considered for each rat. Only the scores
of rats that survived to postoperative day 30 were included.
On day 30, all animals were sacrificed for anatomical and
pathological evaluation. In this way, the results of 10 con-
trol rats were compared with those of 19 rats of the NT-3
group. An overdose of anesthetic pentobarbital (400 mg/
kg — 10 times the usual dose) was used, and the spinal
cord were removed for histological evaluation. The same,
although more extended, laminectomy techniques were
used to remove the spinal cord. The anatomical and patho-
logical specimens of spinal cord were preserved in indi-
vidual jars containing 10% formalin solution. The injured
segment and its cranial and caudal margins were separated
from the rest of the specimen. Each segment of the spinal
cord was cross-sectioned with a micrometer into thin slices,
and each slice was fixed and stained with hematoxylin-
eosin. After this procedure, the nerve tissue was examined
under an ordinary optical microscope.
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The histological analysis included both the injury site and
its macroscopically intact margins. In this way, it was pos-
sible to divide the spinal cord segment into 3 zones: the in-
jury zone, the cranial zone, and the caudal zone. Each was
analyzed separately according to anatomical and pathologi-
cal criteria as follows. These criteria correspond to the fol-
lowing tissue injury stages: hyperemia, cell infiltrate, degen-
eration of nerve substances, necrosis. The first 3 are consid-
ered early responses to an aggressive factor and the last one
is the delayed response. Each criterion was scored based on
severity, as 0 = absent, 1 = mild, 2 = moderate, and 3 = in-
tense (Table 1). Finally, these 4 scores were added to obtain
a final index (Table 2).
The results obtained by functional and histological stud-
ies were analyzed using Windows Excel, Prisma, and
Primer software. Excel produced comparative graphs for
best data visualization. Prisma and Primer allowed us to
perform the statistical study of intergroup differences. We
also used the Mann-Whitney and Fisher statistical tests. The
Mann-Whitney nonparametric test was chosen because the




Tables 3 and 4 show the scores for each rat in the
weekly evaluations. The average scores of all rats in each
group at every weekly evaluation was used for compari-
sons. Figure 2 shows the comparative analysis of scores
versus time. It can be seen that the values of the BBB evalu-
ation curve in group NT-3 was superior to that found in
the control group. This difference is statistically significant
as shown by the Mann-Whitney test on postoperative days
9, 16, 23, and 30; (P = 0.005, 0.0269; 0.004, and 0.004,
Table 1 - Specific pathoanatomical index
CritERIA 0 1 2 3
Hyperemia Absent Mild Moderate Severe
Cellular infiltrate Absent Mild Moderate Severe
Nerve substance Absent Mild Moderate Severe
degeneration
Necrosis Absent Mild Moderate Severe
Table 2 - Final pathoanatomical index
final Score SEVERITY
0 No damage
1 – 4 Mild damage
5 – 8 Moderate damage
9 – 12 Severe damage
Table 3 - Functional evaluation, control group
RATS Postoperative Postoperative Postoperative Postoperative Postoperative
Day2 Day 9 Day 16 Day 23 Day 30
Control 1 0 0.5 3.5 3.5 6
Control 2 0 0.5 1 5 4
Control 3 0 8 10 10 11
Control 5 0 0 1 1 0.5
Control 6 0 0.5 7 9 9
Control 7 0.5 6 9 10 11
Control 8 0 0 5 3 3
Control 9 0 1 7 8 9.5
Control 10 0 7.5 8.5 10 9.5
Control 11 0 0.5 7.5 8 11
Mann-Whitney Test: p (2nd PO) = 0.4902.
 p (9th PO) = 0.0054.
 p (16th PO) = 0.0269.
 p (23rd PO) = 0.0044.
 p (30th PO) = 0.0044.
Figure 2 - Control and NT-3 Groups Functional Analysis
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respectively). Therefore, it can be said that the group re-
ceiving intraperitoneal treatment with NT-3 presented im-
proved locomotor recovery when compared with the dis-
tilled water placebo treated group.
Histological results
The comparative analysis used the averages of the fi-
nal indexes divided by zones (Figure 3) and the statistical
study used the Mann-Whitney test.
The values of each segment of each rat and each group
are shown in Tables 5 and 6. Results show that the NT-3
group presented a lower degree of tissue damage when
Table 4 - Functional evaluation, NT-3 group
RATS Postoperative Postoperative Postoperative Postoperative Postoperative
Day2 Day 9 Day 16 Day 23 Day 30
Treated 1 0 3.5 5 8 9
Treated 2 0 3.5 4 6 6
Treated 3 0 3 3 7.5 7.5
Treated 4 0 7 8 12 12
Treated 5 0 7 10 11 11
Treated 6 0 12 12 16 21
Treated 7 0 4.5 8.5 13 13
Treated 8 0 8 10 13 13
Treated 9 0.5 1 7 10 10
Treated 10 0 8 10 11 12
Treated 11 0 2.5 8 10 11
Treated 12 0 4.5 9.5 10 13
Treated 13 0 7 10 10 12
Treated 14 0 2 2.5 6 6
Treated 15 0 7.5 10 10 12
Treated 16 0 7 9.5 9 9.5
Treated 17 0 4 7 9 10
Treated 18 2 8 12 17 17
Treated 19 0 8 11 12 13
Table 6 - Final histological score, NT-3 group
RATS Injury zone Cranial zone Caudal zone
Treated 1 12 5 5
Treated 2 12 7 7
Treated 3 9 5 5
Treated 4 12 5 5
Treated 5 11 5 5
Treated 6 11 4 4
Treated 7 12 4 4
Treated 8 10 4 4
Treated 9 8 6 6
Treated 10 6 5 5
Treated 11 11 4 4
Treated 12 12 5 5
Treated 13 11 6 6
Treated 14 11 4 4
Treated 15 7 3 3
Treated 16 9 4 4
Treated 17 11 6 6
Treated 18 6 5 5
Treated 19 9 2 2
Table 5 - Final histological score, control group
RATS Injury zone Cranial zone Caudal zone
Control 1 12 7 7
Control 2 12 10 10
Control 3 12 2 2
Control 5 12 5 5
Control 6 12 2 2
Control 7 8 1 1
Control 8 10 3 3
Control 9 11 2 2
Control 10 10 3 3
Control 11 10 6 6
Mann-Whitney Test: p (injury) = 0,1343; p (cranial) = 0,13; p (caudal) =
0,13.
Figure 3 - Comparative Histological Score Control vs NT-3 Groups
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compared with the control group at the injury site itself,
while the injury extent was greater in the cranial and cau-
dal zones, although these differences were not statistically
significant (P > 0.05).
Figures 4, 5, and 6 show that in the NT-3 group the de-
layed response to tissue aggression (necrosis) was notably
reduced when compared with the control group in all seg-
ments. However, the reduction of acute responses in the NT-
3 group (hyperemia, inflammation infiltrate, and nerve de-
generation) at the injury site was more moderate; these re-
sponses were exacerbated in the cranial and caudal zones
of the NT-3 group in relation to the control group. The
treatment with NT-3 was beneficial, although not statisti-
cally significant.
Mortality
There were no deaths in the NT-3 group, whereas in
the control group there were 4 deaths (28,5%) (Figure 7).
Mann-Whitney Test: p (necrosis) = 0.0586.
Figure 4 - Comparison of Specific Scores in the Injury Site between Control
and NT-3 Groups
Mann-Whitney Test: p (necrosis) = 0.3339.
Figure 5 - Comparison of Specific Scores in the Cranial Zone between
Control and NT-3 Groups
Mann-Whitney Test: p (necrosis) = 0.3339.
Figure 6 - Comparison of Specific Scores in the Caudal Zone between
Control and NT-3 Groups
Fisher Test: p = 0,024.
Figure 7 - Deaths Rate in Control and NT-3 Groups
This difference was statistically significant (P = 0.024).
Therefore, it can be said that the treatment with NT-3 was
protective in our trial.
Frequency of hematuria
The frequency of hematuria in the NT-3 group was
lower than in the control group (74% vs 100%, respectively,
a difference of 26%); however, this difference was not sta-
tistically significant (P = 0.057) ( Figure 8 ).
DISCUSSION
Spinal cord injury in a rat model using the NYU
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impactor was chosen because it determines a standardized
neural contusion and is practical, as previously shown.11 The
BBB locomotor scoring scale was also used because of its
wide acceptance in the international literature as a repro-
ducible, practical method of functional analysis.8
The benefits provided by intraperitoneal treatment with
NT-3 were impressive, as shown by the improved locomo-
tor recovery and reduced mortality. These results were sta-
tistically significant.
The benefit as revealed by histology as well as the ben-
efit in terms of renal complications was not statistically sig-
nificant. Although the benefit concerning renal complica-
tions in the treatment group was not statistically signifi-
cant, it should be noted that there was a 26% reduction in
Fisher Test: p = 0.057
Figure 8 - Hematuria Rate in Control and NT-3 Groups
the incidence of hematuria in that group. Histologically,
the NT-3 group showed that the most important action of
this drug resides in the reduction of the extent of necrosis,
the late, irreversible phase of tissue aggression. The acute
phase responses (hyperemia, inflammation, and nerve de-
generation) did not improve with this neurotrophic agent.
Although not statistically significant, these findings help
explain its mechanism of action.
The fact that NT-3 promoted improved motor recovery
that was not revealed histologically might have been due
to one of the following possibilities: (1) technical limita-
tions of histological analysis using optical microscopy and
hematoxylin-eosine staining—the use of immunohisto-
chemical markers would be a more precise manner to evalu-
ate the neural tissue or (2) the short follow-up period (1
month), which may have been insufficient to show identi-
fiable histological changes, since more time might be nec-
essary to observe anatomical and functional agreement.
Alternatively, this dissociation might persist regardless of
the histological technique or the follow-up period adopted.
Our results are in agreement with previously reported
data in terms of the importance of NT-3 in the optimiza-
tion of neurological recovery of these injured rats. How-
ever, the technique that we used to administer the drug (in-
traperitoneal injection) has advantages over the intrathecal
administration used in previous studies1-12 , being less in-
vasive and more practical.
Further studies are necessary to define the role of
neurotrophin-3 as a therapeutical option for patients suf-
fering from radical spinal cord trauma.
RESUMO
Narazaki DK, de Barros Filho TEP, de Oliveira CRGCM,
Cristante AF, Iutaka AS, Marcon R, Oliveira RP. Regene-
ração medular: a ação do neurotrophin-3 sobre a lesão me-
dular de ratos. CLINICS. 2006;61(5):453-60.
OBJETIVO: Por muitos anos acreditou-se que a regene-
ração medular não fosse factível. Atualmente porém, exis-
tem várias experiências utilizando fatores neurotróficos,
células troncos, enxerto de medula fetal, enxerto de nervo
periférico e anticorpos contra proteínas associadas a mielina
que sugerem o contrário. Esta pesquisa estudou a ação de
um dos mais novos neurotróficos, o Neurotrophin-3.
MÉTODOS: As lesões medulares foram realizadas atra-
vés do New York University impator, método experimental
de produção de lesão medular padronizada. Foram utiliza-
dos 33 ratos divididos em 2 grupos. Um grupo controle com
administração intraperitoneal de água destilada e um gru-
po tratamento, tratado com Neurotrophin-3 por via
intraperitoneal.
RESULTADOS: Observamos que a curva de recuperação
locomotora, segundo a escala de Basso, Beattie e
Bresnahan, do grupo Neurotrophin-3 foi superior à do grupo
controle (p < 0,05); a administração de Neurotrophin-3 de-
terminou ausência de mortes no grupo tratamento, enquanto
o grupo controle apresentou taxa de mortalidade de 28,5%
(p = 0,026). Os outros parâmetros (taxa de hematúria e aná-
lise histológica) não apresentaram diferenças estatistica-
mente significantes.
CONCLUSÕES: Existe forte relação entre a aplicação de
Neurotrophin-3 em ratos com lesão medular e melhor re-
cuperação funcional.
UNITERMOS: Lesões da medula espinhal. Regeneração
nervosa. Ratos. Fatores de crescimento neural. 
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